Etoposide soft capsule combined with anlotinib in the third-line treatment of advanced non-small cell lung cancer: a retrospective cohort study.

Dai, Yi-Jun; Qiu, Yan-Ru; Lin, Jian-Guang; Dai, Yang-Bin; Su, Yun-Xia; Yamada, Tadaaki; Uematsu, Shugo; Xu, Tian-Wen

Dai, Yi-Jun; Qiu, Yan-Ru; Lin, Jian-Guang; Dai, Yang-Bin; Su, Yun-Xia; Yamada, Tadaaki; Uematsu, Shugo; Xu, Tian-Wen.

Afiliación

Dai YJ; Department of Medical Oncology, The Second Affiliated Hospital of Fujian Medical University, Quanzhou, China.
Qiu YR; Department of Medical Oncology, The Second Affiliated Hospital of Fujian Medical University, Quanzhou, China.
Lin JG; Department of Medical Oncology, The Second Affiliated Hospital of Fujian Medical University, Quanzhou, China.
Dai YB; Department of Medical Oncology, The Second Affiliated Hospital of Fujian Medical University, Quanzhou, China.
Su YX; Department of Medical Oncology, The Second Affiliated Hospital of Fujian Medical University, Quanzhou, China.
Yamada T; Department of Pulmonary Medicine, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan.
Uematsu S; Respiratory Disease Center, Showa University Northern Yokohama Hospital, Yokohama, Japan.
Xu TW; Department of Medical Oncology, The Second Affiliated Hospital of Fujian Medical University, Quanzhou, China.

J Thorac Dis ; 15(10): 5680-5688, 2023 Oct 31.

Article en En | MEDLINE | ID: mdl-37969289

Palabras clave

Etoposide soft capsule; advanced; anlotinib; non-small cell lung cancer (NSCLC)

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: J Thorac Dis Año: 2023 Tipo del documento: Article País de afiliación: China

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google